'Pharmaceutical vehicles' is not a widely recognized or formally defined term in medical or pharmaceutical sciences. However, it is possible that the term may refer to 'drug delivery systems' or 'carriers' that are used to enhance the efficacy and safety of drugs by improving their bioavailability, stability, and targeted distribution within the body.

These carriers can be made up of various materials such as liposomes, nanoparticles, micelles, dendrimers, or polymeric systems that encapsulate or conjugate with drugs to protect them from degradation, enhance their solubility, and prolong their circulation time in the body.

The use of pharmaceutical vehicles has gained significant attention in recent years due to their potential to improve drug therapeutic outcomes, reduce side effects, and enable the delivery of drugs that are otherwise difficult to administer or have poor pharmacokinetics.

'Motor dysfunction' är ett medicinskt begrepp som refererar till någon form av störning eller skada på det centrala nervsystemet som påverkar individens förmåga att kontrollera och koordinera muskelrörelser. Detta kan leda till problem med balans, rörelsekoordination, styrka och finmotorik. Motorfordon kan vara relaterat till skador på hjärnan eller ryggmärgen, neurologiska sjukdomar som Parkinson's eller Multiple sklerosis, eller muskulära förhållanden som muskeldystrofi. Behandlingen av motorfordon kan innebära medicinska behandlingar, terapi, ortoser eller annan teknik för att underlätta rörelser och förbättra funktionen.